GenoFocus Acquires Patent for the Oral Plaque-Fighting Enzyme Mutanase
페이지 정보
작성자 관리자 작성일22-01-24 11:37 조회3,147회 댓글0건관련링크
본문
GenoFocus Acquires Patent for the Oral Plaque-Fighting Enzyme Mutanase
GenoFocus is pleased to announce that we have acquired a patent for mutanase, an oral care enzyme designed to combat plaque. GF Mutanase is alpha 1,3-glucanase which has a specific oral plaque binding domain. Therefore, it can maintain its catalytic activity even after users rinse their mouths.
GenoFocus plans to promote GF Mutanase to the global market this year.
